What are the risks of investing in ANIP?
A
What are the risks of investing in ANIP?
🦉
ANI Pharmaceuticals, Inc. (ANIP)
Company Overview
Sector / IndustryHealthcare / Drug Manufacturers - Specialty & Generic
CEONikhil Lalwani
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations....
Key Executives
| Name | Title |
|---|---|
| Chad Gassert | Senior Vice President of Corporate Development & Strategy |
| Christopher K. Mutz | Senior Vice President & Head of Rare Disease |
| Elizabeth Powell | Chief Compliance Officer & Head of Legal of Rare Disease |
| Krista L. Davis | Senior Vice President & Chief Human Resources Officer |
| Mary Pao | Chief Medical Officer |
| Meredith W. Cook | Senior Vice President, General Counsel & Corporate Secretary |
Financial Health
Risk Assessment
Weather Score0/100
RegimeN/A